- Nestle India‘s 1Q net income topped estimates at 9.34 billion rupees, representing a 26% increase y/y.
- The company’s total revenue came to 52.7 billion rupees, up 9.1% y/y, against an estimated 52.36 billion rupees.
- Total costs also rose by 4.7% y/y to 40.5 billion rupees.
- A dividend per share of 8.50 rupees has been declared by the company.
- A joint venture with DR.REDDY’s Laboratories has been entered into by Nestle India.
- The firm has recommended a final dividend of INR 8.50 per share.
- Nestle India has approved the launch of Nespresso in India.
- The company currently has 16 buys, 14 holds, and 8 sells from investors.
A look at Nestle India Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Nestle India is positioned for a promising long-term outlook. The company’s strength lies in its strong dividend and momentum scores, indicating a solid track record of consistent dividends and positive market momentum. Nestle India also scores well on resilience, highlighting its ability to withstand economic fluctuations and challenges. While the growth score is moderate, the overall outlook for Nestle India appears optimistic, supported by its diverse product offerings in the food and beverage sector.
Nestle India Ltd., known for manufacturing popular milk products and food items, such as Everyday dairy whitener, Cerelac weaning foods, Maggi noodles, and Nescafe coffee, demonstrates a balanced mix of value, dividend, growth, resilience, and momentum based on the Smartkarma Smart Scores. With a focus on quality products and a strong presence in the market, Nestle India appears well-positioned for continued success in the competitive food industry landscape.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
